[go: up one dir, main page]

DK0973544T3 - Immuntolerant prothrombinkomplekspræparat - Google Patents

Immuntolerant prothrombinkomplekspræparat

Info

Publication number
DK0973544T3
DK0973544T3 DK98913425T DK98913425T DK0973544T3 DK 0973544 T3 DK0973544 T3 DK 0973544T3 DK 98913425 T DK98913425 T DK 98913425T DK 98913425 T DK98913425 T DK 98913425T DK 0973544 T3 DK0973544 T3 DK 0973544T3
Authority
DK
Denmark
Prior art keywords
prothrombin complex
complex preparation
immune tolerant
preparation
tolerant
Prior art date
Application number
DK98913425T
Other languages
English (en)
Inventor
Hans-Peter Schwarz
Peter Turecek
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0059497A external-priority patent/AT405608B/de
Priority claimed from AT159297A external-priority patent/AT406824B/de
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0973544T3 publication Critical patent/DK0973544T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK98913425T 1997-04-08 1998-04-06 Immuntolerant prothrombinkomplekspræparat DK0973544T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0059497A AT405608B (de) 1997-04-08 1997-04-08 Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
AT159297A AT406824B (de) 1997-09-19 1997-09-19 Immuntolerante prothrombinkomplex-präparation
PCT/AT1998/000091 WO1998044942A1 (de) 1997-04-08 1998-04-06 Immuntolerante prothrombinkomplex-präparation

Publications (1)

Publication Number Publication Date
DK0973544T3 true DK0973544T3 (da) 2001-10-15

Family

ID=25593261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98913425T DK0973544T3 (da) 1997-04-08 1998-04-06 Immuntolerant prothrombinkomplekspræparat

Country Status (14)

Country Link
US (1) US6358534B1 (da)
EP (1) EP0973544B1 (da)
JP (1) JP3976351B2 (da)
AT (1) ATE202483T1 (da)
AU (1) AU737566B2 (da)
BR (1) BR9807936A (da)
CA (1) CA2285935C (da)
DE (1) DE59800935D1 (da)
DK (1) DK0973544T3 (da)
ES (1) ES2160410T3 (da)
NO (1) NO994822L (da)
PT (1) PT973544E (da)
SK (1) SK139099A3 (da)
WO (1) WO1998044942A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA159597A (de) * 1997-09-19 2000-09-15 Immuno Ag Präparat zur behandlung von blutgerinnungsstörungen
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
AU2001291652B2 (en) * 2000-10-02 2007-09-13 Novo Nordisk Health Care Ag Factor VII glycoforms
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
DE60221553T2 (de) * 2001-10-02 2008-04-10 Novo Nordisk Health Care Ag Verfahren zur herstelllung rekombinanter proteine in eukaryontischen zellen
US6989891B2 (en) 2001-11-08 2006-01-24 Optiscan Biomedical Corporation Device and method for in vitro determination of analyte concentrations within body fluids
EP1523327A1 (de) * 2002-07-23 2005-04-20 Bio-Products & Bio-Engineering Aktiengesellschaft Thrombingenerierfahige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
DK1528930T3 (da) * 2002-07-23 2009-08-03 Bio & Bio Licensing Sa Thrombindannelsesdygtige og thrombinholdige farmaceutiske præparater af virksomt stof samt lægemidler
US7364562B2 (en) * 2005-10-06 2008-04-29 Optiscan Biomedical Corp. Anti-clotting apparatus and methods for fluid handling system
US8425444B2 (en) * 2006-04-11 2013-04-23 Optiscan Biomedical Corporation Anti-clotting apparatus and methods for fluid handling system
WO2008144575A2 (en) 2007-05-18 2008-11-27 Optiscan Biomedical Corporation Fluid injection and safety system
NZ603997A (en) * 2007-12-27 2013-02-22 Baxter Int Chemically Modified Factor IX
JP6088435B2 (ja) 2010-12-15 2017-03-01 バクスアルタ ゲーエムベーハー 導電率グラディエントを用いる溶出液収集
EP3981873A1 (en) 2012-06-29 2022-04-13 EMD Millipore Corporation Methods for inactivating viruses during a protein purification process
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
RU2559576C1 (ru) * 2014-06-09 2015-08-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения вирусбезопасного полного протромбинового комплекса
EP3205665A1 (en) * 2016-02-11 2017-08-16 Octapharma AG Method of separating factor viii from blood products

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
JPH0686385B2 (ja) * 1980-01-28 1994-11-02 バクスタ−、インタ−ナショナル、インコ−ポレイテッド 活性プロトロンビン複合体組成物およびその製造方法
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
US4412985A (en) 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
US4382083A (en) 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4673733A (en) 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
US5156973A (en) 1988-11-23 1992-10-20 Edward Shanbrom Antiviral blood sampling process and apparatus
JP3145696B2 (ja) 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
ATE203679T1 (de) 1992-01-27 2001-08-15 Baxter Int Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen
FI952196A0 (fi) 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
DE19531637A1 (de) 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
US6686191B1 (en) 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin

Also Published As

Publication number Publication date
AU737566B2 (en) 2001-08-23
BR9807936A (pt) 2000-02-22
JP2001524953A (ja) 2001-12-04
EP0973544A1 (de) 2000-01-26
ATE202483T1 (de) 2001-07-15
NO994822L (no) 1999-12-02
DE59800935D1 (en) 2001-08-02
US6358534B1 (en) 2002-03-19
WO1998044942A1 (de) 1998-10-15
AU6812198A (en) 1998-10-30
CA2285935A1 (en) 1998-10-15
JP3976351B2 (ja) 2007-09-19
EP0973544B1 (de) 2001-06-27
PT973544E (pt) 2001-12-28
NO994822D0 (no) 1999-10-04
ES2160410T3 (es) 2001-11-01
CA2285935C (en) 2011-01-18
SK139099A3 (en) 2000-06-12

Similar Documents

Publication Publication Date Title
DK0973544T3 (da) Immuntolerant prothrombinkomplekspræparat
MXPA02004666A (es) Gelatinas recombinantes.
FI963070A0 (fi) Klooripyrimidiinivälituotteita
MY117805A (en) Resorcinol derivatives
MXPA03005730A (es) Metodo de un paso para producir una estructura de pelicula con capacidad para respirar elastica.
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
BR0017043A (pt) Imidazo[1,3,5]triazinonas e sua aplicação
SE9804003D0 (sv) A method of producing drug particles
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
PL374080A1 (en) Processes for the preparation of fibrinogen
BG105197A (en) Polymorph form of a medicament
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
AP2001002274A0 (en) Rescorcinol derivatives.
GB2358137B (en) Compound
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
NO20033413D0 (no) Krystallmodifisering av et syklisk depsipeptid med forbedret aktivitet
HRP20050611B1 (hr) Kombinacijski lijek
SE9803107D0 (sv) Novel Compunds
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
MXPA01006319A (es) Uso de los antagonistas del receptor para 5ht, para el tratamiento de sindrome de fatiga cronica.
FI972389A0 (fi) Uusi menetelmä ranitidiinin valmistamiseksi
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine